{"id":10472,"date":"2024-05-31T10:17:21","date_gmt":"2024-05-31T08:17:21","guid":{"rendered":"https:\/\/semmelweis.hu\/tdk\/?page_id=10472"},"modified":"2025-07-15T13:53:27","modified_gmt":"2025-07-15T11:53:27","slug":"belgyogyaszati-es-onkologiai-klinika-rektori-palyazat","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/tdk\/rektori-palyazat\/rektori-palyazat-meghirdetett-temak\/belgyogyaszati-es-onkologiai-klinika-rektori-palyazat\/","title":{"rendered":"Belgy\u00f3gy\u00e1szati \u00e9s Onkol\u00f3giai Klinika &#8211; Rektori p\u00e1ly\u00e1zat"},"content":{"rendered":"<h2>2025\/2026-os tan\u00e9v<\/h2>\n<ul>\n<li><strong>Antihypertenz\u00edv ter\u00e1pia k\u00fcl\u00f6nb\u00f6z\u0151 k\u00f3rk\u00e9pekben<\/strong><br \/>\nDr. Barna Istv\u00e1n (PhD)<\/li>\n<li><strong>Obezit\u00e1s diagnosztik\u00e1ja <br \/>\n<\/strong>Dr. Barna Istv\u00e1n<\/li>\n<li><strong>Obezit\u00e1s kezel\u00e9se<br \/>\n<\/strong>Dr. Barna Istv\u00e1n<\/li>\n<li><strong>Ter\u00e1pia-rezisztens hypertonia\u00a0 \u00a0\u00a0<\/strong><br \/>\nDr. Tisl\u00e9r Andr\u00e1s (PhD)<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><strong>ENDOKRINOL\u00d3IA-DIABETOL\u00d3GIA-ANYAGCSERE<\/strong><\/p>\n<ul>\n<li><strong>\u00c9letmin\u0151s\u00e9get befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k vizsg\u00e1lata kezelt primer hyperthyreosisban<br \/>\n<\/strong>Dr. Bakos Bence (PhD)<\/li>\n<li><strong>A metformin diabetesen t\u00fali ter\u00e1pi\u00e1s hat\u00e1sai<br \/>\n<\/strong>Dr. Ger\u0151 L\u00e1szl\u00f3 (MTA doktora)<\/li>\n<\/ul>\n<ul>\n<li><strong>V\u00e9rcukor-adatb\u00e1zisok elemz\u00e9se<br \/>\n<\/strong>Dr. Kempler P\u00e9ter (MTA doktora)<\/li>\n<li><strong>Auton\u00f3m \u00e9s szenzoros neuropathia diabetes fokozott kock\u00e1zat\u00e1nak kitett, de sz\u00e9nhidr\u00e1t-anyagcserezavarban nem szenved\u0151 betegekben<\/strong>. Dr. Kempler P\u00e9ter (MTA doktora)<\/li>\n<li><strong>Geszt\u00e1ci\u00f3s diabetes \u00e9s kardiovaszkul\u00e1ris rizik\u00f3\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tab\u00e1k Gy. \u00c1d\u00e1m (PhD)<\/li>\n<\/ul>\n<ul>\n<li><strong>Geszt\u00e1ci\u00f3s diabetes prediktorai\u00a0<\/strong><br \/>\nDr. Tab\u00e1k Gy. \u00c1d\u00e1m (PhD)<\/li>\n<li><strong>A csontanyagcsere v\u00e1ltoz\u00e1sai vesek\u0151betegekben \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A csontt\u00f6r\u00e9si kock\u00e1zat felm\u00e9r\u00e9s\u00e9nek modern m\u00f3dszerei osteoporosisban \u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A D-vitamin szerepe a mozg\u00e1sszervi betegs\u00e9gekben \u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>Modern csontvizsg\u00e1l\u00f3 elj\u00e1r\u00e1sok klinikai alkalmaz\u00e1sa\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A kalcium- \u00e9s csontanyagcsere v\u00e1ltoz\u00e1sai k\u00fcl\u00f6nf\u00e9le metabolikus osteopathi\u00e1kban \u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>Oszteodenzitometria \u00e9s egy\u00e9b csontvizsg\u00e1l\u00f3 elj\u00e1r\u00e1sok\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A csontmin\u0151s\u00e9g vizsg\u00e1lata ultrahangm\u00f3dszerrel<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A csont t\u00f6r\u00e9kenys\u00e9g t\u00e9nyez\u0151i, vizsg\u00e1lata \u00e9s befoly\u00e1sol\u00e1sa\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>Szekunder oszteopor\u00f3zisok\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A kalcium vesek\u0151betegs\u00e9g k\u00f3rsz\u00e1rmaz\u00e1sa \u00e9s kezel\u00e9se\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>A test\u00f6sszet\u00e9tel vizsg\u00e1lata\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora)<\/li>\n<li><strong>Akromeg\u00e1li\u00e1s betegek csontanyacsere \u00e9s test\u00f6sszet\u00e9tel vizsg\u00e1lata\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Csaba (MTA doktora), Dr. M\u00e9sz\u00e1ros Szilvia (PhD)<\/li>\n<li><strong>\u00daj patomechanizmusok \u00e9s ter\u00e1pi\u00e1s lehet\u0151s\u00e9gek phaeochromocytom\u00e1ban \u00e9s paragangliom\u00e1ban<\/strong><br \/>\nDr. Igaz P\u00e9ter (MTA doktora)<\/li>\n<li><strong>Az izot\u00f3pkezel\u00e9sek perspekt\u00edv\u00e1i neuroendokrin daganatokban\u00a0\u00a0<br \/>\n<\/strong> Dr. Igaz P\u00e9ter (MTA doktora)<\/li>\n<li><strong>Mell\u00e9kvesek\u00e9reg-carcinoma molekul\u00e1ris alap\u00fa oszt\u00e1lyoz\u00e1sa \u00e9s potenci\u00e1lis \u00faj kezel\u00e9si lehet\u0151s\u00e9gei<\/strong><br \/>\nDr. Igaz P\u00e9ter (MTA doktora)<\/li>\n<li><strong>A kalcium-szenzor receptor g\u00e9nhez k\u00f6thet\u0151 betegs\u00e9gek \u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>Polycyst\u00e1s ovarium szindr\u00f3ma \u00a0\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>N\u00f6veked\u00e9si faktorork, citokinek \u00e9s \u00e1sv\u00e1nyianyag-csere\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>A csontanyagcsere genetik\u00e1ja \u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>A pajzsmirigy tumorok genetik\u00e1ja\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>D-vitamin \u00e9s tumorgenesis \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>A prosztata carcinoma \u00e9s modern diagnosztik\u00e1ja\u00a0\u00a0<\/strong><br \/>\nDr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<li><strong>Az \u00e1llkapocs osteonecrosis genetikai h\u00e1ttere<br \/>\n<\/strong>Dr. Lakatos P\u00e9ter Andr\u00e1s (MTA doktora)<\/li>\n<\/ul>\n<ul>\n<li><strong>A testo\u0308sszete\u0301tel vizsga\u0301lata egy- e\u0301s ke\u0301tpete\u0301j\u0171 ikerpa\u0301rokon\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. M\u00e9sz\u00e1ros Szilvia (PhD)<\/li>\n<li><strong>A denzitometria \u00faj t\u00edpus\u00fa alkalmaz\u00e1sai endokrin k\u00f3r\u00e1llapotokban\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. M\u00e9sz\u00e1ros Szilvia (PhD)<\/li>\n<li><strong>Phenylketonuria feln\u0151ttkorban\u00a0<\/strong><br \/>\nDr. Reismann P\u00e9ter (PhD)<\/li>\n<li><strong>Az osteoporosis genetik\u00e1ja<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A genetikai polimorfizmusok jelent\u0151s\u00e9ge a csontanyagcser\u00e9ben \u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A D-vitamin szerepe az osteoporosis kezel\u00e9s\u00e9ben<\/strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A hyperthyreosis \u00e9s a csontanyagcsere \u00f6sszef\u00fcgg\u00e9sei\u00a0 \u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A genetikai t\u00e9nyez\u0151k hat\u00e1sa a malignus pajzsmirigytumorok kezel\u00e9si hat\u00e9konys\u00e1g\u00e1ra\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>Genetikai t\u00e9nyez\u0151k szerepe a malignus pajzsmirigy tumorok diagnosztiz\u00e1l\u00e1s\u00e1ban\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>D-vitamin-hi\u00e1ny nem csontrendszeri hat\u00e1sai \u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>Ritka csontbetegs\u00e9gek\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>Az osteoporosis modern kezel\u00e9se\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A csontanyagcsere betegs\u00e9gek diagnosztik\u00e1ja\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>A hypoparathyreosis diagnosztik\u00e1ja \u00e9s kezel\u00e9se\u00a0<\/strong><br \/>\nDr. Tak\u00e1cs Istv\u00e1n (MTA doktora)<\/li>\n<li><strong>Mell\u00e9kvesek\u00e9reg karcinoma komplex kezelel\u00e9s\u00a0\u00a0<\/strong><br \/>\nDr. T\u00f3th Mikl\u00f3s (MTA doktora) \/Dr. P\u00f3csai K\u00e1roly (PhD)<\/li>\n<li><strong>MEN2A \u00e9s MEN2B szindr\u00f3m\u00e1s beteganyagunk klinikai jellemz\u0151i<\/strong><br \/>\nDr. T\u00f3th Mikl\u00f3s (MTA doktora) \/Dr. Nagy G\u00e9za (PhD)<\/li>\n<li><strong>Mell\u00e9kpajzsmirigy carcinom\u00e1s betegek klinikopatol\u00f3giai jellemz\u0151i\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. T\u00f3th Mikl\u00f3s (MTA doktora) \/Dr. T\u0151ke Judit (PhD)<\/li>\n<li><strong>Mell\u00e9kvesek\u00e9reg karcinoma komplex prognosztik\u00e1ja\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. T\u00f3th Mikl\u00f3s (MTA doktora) \/Dr. T\u0151ke Judit (PhD)<\/li>\n<li><strong>Congenitalis adrenalis hyperplasi\u00e1s betegek feln\u0151ttkori gondoz\u00e1s\u00e1nak szempontjai\u00a0<\/strong><br \/>\nDr. T\u0151ke Judit (PhD)<\/li>\n<li><strong>Turner szindr\u00f3ma gondoz\u00e1sa feln\u0151tt korban<br \/>\n<\/strong>Dr. Sz\u00fccs Nikolette (PhD)<\/li>\n<li><strong>Hypophysis tumoros betegek multidisciplin\u00e1ris gondoz\u00e1sa<br \/>\n<\/strong>Dr. Sz\u00fccs Nikolette (PhD)<\/li>\n<li><strong>Acromegalia multidisciplin\u00e1ris megk\u00f6zel\u00edt\u00e9se<br \/>\n<\/strong>Dr. Sz\u00fccs Nikolette (PhD)<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><strong>GASZTROENTEROL\u00d3GIA-HEPATOL\u00d3GIA<\/strong><\/p>\n<ul>\n<li><strong>\u00a0<\/strong><strong style=\"font-size: 1rem\">A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek epidemiol\u00f3gi\u00e1ja, k\u00f3rlefoly\u00e1sa<br \/>\n<\/strong>Dr. G\u00f6nczi L\u00f3r\u00e1nt (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek gy\u00f3gyszeres kezel\u00e9se, seb\u00e9szeti ell\u00e1t\u00e1sa<br \/>\n<\/strong>Dr. G\u00f6nczi L\u00f3r\u00e1nt (PhD)<\/li>\n<li><strong style=\"font-size: 1rem\">Biol\u00f3giai ter\u00e1pi\u00e1k hat\u00e9konys\u00e1g\u00e1nak felm\u00e9r\u00e9se, betegs\u00e9g kimenetelt el\u0151rejelz\u0151 faktorok a gyullad\u00e1sos b\u00e9lbetegek k\u00f6r\u00e9ben<br \/>\n<\/strong>Dr. G\u00f6nczi L\u00f3r\u00e1nt (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek patogenezise, genetik\u00e1ja, sz\u00f6v\u0151dm\u00e9nyei \u00e9s kezel\u00e9si lehet\u0151s\u00e9gei\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek k\u00f3rlefoly\u00e1s\u00e1nak el\u0151rejelz\u00e9se, a klinikai, az endoszk\u00f3pos \u00e9s a biomarkerek szerepe\u00a0\u00a0<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek t\u00e1rsadalmi hat\u00e1sai: munkak\u00e9pess\u00e9g \u00e9s \u00e9letmin\u0151s\u00e9g\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek b\u00e9lrendszeren k\u00edv\u00fcli megnyilv\u00e1nul\u00e1sai, azok gyakoris\u00e1ga \u00e9s kapcsolata a betegs\u00e9g aktivit\u00e1s\u00e1val<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek \u00fajabb ter\u00e1pi\u00e1s lehet\u0151s\u00e9gei<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>Als\u00f3 \u00e9s fels\u0151 gastrointestinalis v\u00e9rz\u00e9sek gyakoris\u00e1ga, okai \u00e9s kimenetele<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A v\u00e9konyb\u00e9l vizsg\u00e1lat\u00e1nak \u00fajabb lehet\u0151s\u00e9ge: kett\u0151s-ballonos endoszk\u00f3pia\u00a0\u00a0<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A gyullad\u00e1sos b\u00e9lbetegs\u00e9gek epidemiol\u00f3gi\u00e1ja, patogenezise, kezel\u00e9se \u00e9s sz\u00f6v\u0151dm\u00e9nyei: biol\u00f3giai kezel\u00e9s hat\u00e1s\u00e1ra a k\u00f3rh\u00e1zi kezel\u00e9s gyakoris\u00e1g\u00e1nak v\u00e1ltoz\u00e1sa\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Ili\u00e1s \u00c1kos (PhD)<\/li>\n<li><strong>A mesters\u00e9ges intelligencia \u00e9rz\u00e9kenys\u00e9g\u00e9nek vizsg\u00e1lata, v\u00e9konyb\u00e9l kapszula endoszk\u00f3pia sor\u00e1n detekt\u00e1lt l\u00e9zi\u00f3kon<\/strong><br \/>\nDr. Barkai L\u00e1szl\u00f3 (PhD)<\/li>\n<li><strong>Hepatitis B, hepatitis C \u00e9s hepatocellularis carcinoma<\/strong><br \/>\nKuczyn\u00e9 Dr. Folhoffer Anik\u00f3 (PhD)<\/li>\n<li><strong>A hepatikus encephalopathia. Patomechanizmus, klinikum \u00e9s kezel\u00e9s\u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>\u00daj lehet\u0151s\u00e9gek a B hepatitis kezel\u00e9s\u00e9re \u00e9s megel\u0151z\u00e9s\u00e9re \u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>A primer m\u00e1jr\u00e1k. Patogenezis, diagnosztika \u00e9s kezel\u00e9s\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>Primer biliaris cholangitis<br \/>\n<\/strong> Dr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>Hepatikus osteopathia\u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>Wilson-betegs\u00e9g \u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>Gy\u00f3gyszer okozta m\u00e1jk\u00e1rosod\u00e1s<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>A m\u00e1jtranszplant\u00e1ci\u00f3 indik\u00e1ci\u00f3ja, el\u0151k\u00e9sz\u00edt\u00e9s \u00e9s ut\u00f3gondoz\u00e1s\u00a0 \u00a0\u00a0<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>Az autoimmun m\u00e1jbetegs\u00e9gek diagnosztik\u00e1ja \u00e9s ter\u00e1pi\u00e1ja \u00a0\u00a0<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<li><strong>A D-vitamin \u00e9s a m\u00e1jr\u00e1k<\/strong><br \/>\nDr. Szalay Ferenc (MTA doktora)<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><strong>HEMATOL\u00d3GIA-HEMOSZT\u00c1ZIS<\/strong><\/p>\n<ul>\n<li><strong>Az immunkemoter\u00e1pia helye \u00e9s szerepe a malignus lymphom\u00e1k kezel\u00e9s\u00e9ben\u00a0\u00a0<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>A kr\u00f3nikus myeloproliferat\u00edv betegs\u00e9gek: a molekul\u00e1ris patogenezist\u0151l a mindennapi ter\u00e1pi\u00e1s gyakorlatig\u00a0<\/strong> \u00a0 \u00a0<br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>Marginalis z\u00f3na lymphoma \u00e9s rokon k\u00f3rk\u00e9pek: patogenezis, diagnosztika \u00e9s kezel\u00e9s\u00a0 \u00a0\u00a0<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>A megfelel\u0151 D vitamin-ell\u00e1totts\u00e1g onko-hematol\u00f3giai vonatkoz\u00e1sai\u00a0\u00a0<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>Hajas sejtes leukaemia: az \u00faj molekul\u00e1ris diagnosztikai eredm\u00e9nyek \u00e9s jelent\u0151s\u00e9g\u00fck\u00a0<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>Familiaris myeloproliferat\u00edv neoplazm\u00e1k<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>A thrombopoetin anal\u00f3g kezel\u00e9s indik\u00e1ci\u00f3i \u00e9s kock\u00e1zatai immunthrombocytopeni\u00e1s purpur\u00e1ban<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>Ritka hematol\u00f3giai betegs\u00e9gek: a korai felismer\u00e9s szerepe a gy\u00f3gyul\u00e1sban\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Demeter Judit (MTA doktora)<\/li>\n<li><strong>A v\u00e9n\u00e1s thromboembolia n\u00e9peg\u00e9szs\u00e9g\u00fcgyi jelent\u0151s\u00e9ge<\/strong><br \/>\nDr. Domj\u00e1n Gyula (CSc)<\/li>\n<li><strong>\u00daj t\u00edpus\u00fa alvad\u00e1sg\u00e1tl\u00f3k alkalmaz\u00e1sa\u00a0<\/strong><br \/>\nDr. Domj\u00e1n Gyula (CSc)<\/li>\n<li><strong>Az antifoszfolipid szindr\u00f3ma okai\u00a0 \u00a0\u00a0<\/strong><br \/>\nDr. Domj\u00e1n Gyula (CSc)<\/li>\n<li><strong>Hughes-szindr\u00f3ma m\u00e1ra a leggyakoribb szerzett tromb\u00f3zishajlam fokoz\u00f3d\u00e1s oka (2020)<\/strong><br \/>\nDr. Domj\u00e1n Gyula (Csc)<\/li>\n<\/ul>\n<p><strong>KARDIOL\u00d3GIA<\/strong><\/p>\n<ul>\n<li><strong>EKG param\u00e9terek vizsg\u00e1lata magas kardiovaszkul\u00e1ris kock\u00e1zat\u00fa betegekben \u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Viktor (PhD)<\/li>\n<li><strong>Ischaemi\u00e1s cerebrovascularis inzultust el\u0151jelz\u0151 echocardiographi\u00e1s param\u00e9terek vizsg\u00e1lata \u00a0\u00a0<\/strong><br \/>\nDr. Horv\u00e1th Viktor (PhD)<\/li>\n<li><strong>Echocardiographi\u00e1s param\u00e9terek vizsg\u00e1lata cs\u00f6kkent gl\u00fck\u00f3ztoleranci\u00e1val rendelkez\u0151 betegekben<\/strong><br \/>\nDr. Horv\u00e1th Viktor (PhD)<\/li>\n<\/ul>\n<p><strong>NEFROL\u00d3GIA<\/strong><\/p>\n<ul>\n<li><strong>ANCA-asszoci\u00e1lt vasculitisek\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Studinger P\u00e9ter (PhD)<\/li>\n<li><strong>Diuretikum-rezisztencia gyakoris\u00e1ga \u00e9s kezel\u00e9si lehet\u0151s\u00e9gei k\u00f3rh\u00e1zban fekv\u0151 betegek k\u00f6r\u00e9ben<br \/>\n<\/strong>Dr. Studinger P\u00e9ter (PhD)<\/li>\n<li><strong>Rituximabkezel\u00e9s glomerularis betegs\u00e9gekben<br \/>\n<\/strong>Dr. Studinger P\u00e9ter (Phd)<\/li>\n<\/ul>\n<ul>\n<li><strong>A hyponatraemia gyakoris\u00e1ga, jelent\u0151s\u00e9ge \u00e9s kezel\u00e9se k\u00f3rh\u00e1zban fekv\u0151 betegek k\u00f6r\u00e9ben<\/strong><br \/>\nDr. Tisl\u00e9r Andr\u00e1s (PhD)<\/li>\n<li><strong>A vesebiopszia klinikai jelent\u0151s\u00e9ge<\/strong><br \/>\nDr. Tisl\u00e9r Andr\u00e1s (PhD)<\/li>\n<li><strong>Orsz\u00e1gos vesebiopszia regiszter szervez\u00e9se \u00e9s fenntart\u00e1sa\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><br \/>\nDr. Tisl\u00e9r Andr\u00e1s (PhD)<\/li>\n<li><strong>Ionzavarok (hyponatraemia, hypomagnesaemia) gyakoris\u00e1ga \u00e9s klinikai \u00f6sszef\u00fcgg\u00e9sei belgy\u00f3gy\u00e1szati oszt\u00e1lyokon \u00a0\u00a0<\/strong><br \/>\nDr. Tisl\u00e9r Andr\u00e1s (PhD)<\/li>\n<li><strong>ANCA-asszoci\u00e1lt glomerulonephritis<br \/>\n<\/strong>Dr. Led\u00f3 N\u00f3ra (PhD)<\/li>\n<\/ul>\n<ul>\n<li><strong>Lupus nephritis<br \/>\n<\/strong>\u00a0Dr. Led\u00f3 N\u00f3ra (PhD)<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><strong>ONKOL\u00d3GIA<\/strong><\/p>\n<ul>\n<li><strong>Immunter\u00e1pi\u00e1k az onkol\u00f3gi\u00e1ban<br \/>\n<\/strong>Dr. Dank Magdolna (PhD)<\/li>\n<\/ul>\n<ul>\n<li><strong>HER-2 pozit\u00edv eml\u0151r\u00e1k gy\u00f3gyszeres kezel\u00e9s\u00e9nek lehet\u0151s\u00e9gei<br \/>\n<\/strong>Dr. Dank Magdolna (PhD)<\/li>\n<\/ul>\n<ul>\n<li><strong>A hepatocellul\u00e1ris karcin\u00f3ma korszer\u0171 ter\u00e1pi\u00e1ja<br \/>\n<\/strong>Dr. Dank Magdolna (PhD)<\/li>\n<li><strong>Sarcopenias obesitas tumoros betegeken<br \/>\n<\/strong>Dr. Dank Magdolna (PhD)<\/li>\n<li><strong>Eml\u0151r\u00e1k primer sziszt\u00e9m\u00e1s kezel\u00e9se<br \/>\n<\/strong>Dr. Szentm\u00e1rtoni Gy\u00f6ngyv\u00e9r (PhD)<\/li>\n<li><strong>Predikt\u00edv \u00e9s prognosztikus markerek eml\u0151r\u00e1kban<br \/>\n<\/strong>Dr. Szentm\u00e1rtoni Gy\u00f6ngyv\u00e9r (PhD)<\/li>\n<li><strong>Biomarkerek szolid daganatokban<br \/>\n<\/strong>Dr. Sz\u00e1sz A. Marcell (PhD)<\/li>\n<li><strong>Neuroendokrin \u00e9s endokrin tumormarkerek kapcsolata szolid tumorokkal<br \/>\n<\/strong>Dr. Herold Zolt\u00e1n (PhD)<\/li>\n<li><strong>Laborat\u00f3riumi \u00e9s klinikopatol\u00f3giai param\u00e9terek id\u0151beli v\u00e1ltoz\u00e1sainak elemz\u00e9se <\/strong><strong style=\"font-size: 1rem\">szolid tumorokban<br \/>\n<\/strong>Dr. Herold Zolt\u00e1n (PhD)<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>A Belgy\u00f3gy\u00e1szati \u00e9s Onkol\u00f3giai Klinika, Onkol\u00f3giai Profil, Gy\u00f3gyszer- Betegbiztons\u00e1gi Kutat\u00f3csoportj\u00e1nak Rektori P\u00e1lyamunkat\u00e9m\u00e1i<\/h3>\n<table style=\"border-collapse: collapse;width: 100%\">\n<tbody>\n<tr>\n<td style=\"width: 49.9636%\" width=\"542\"><strong>Rektori p\u00e1lyamunka c\u00edme<\/strong><\/td>\n<td style=\"width: 49.9636%\" width=\"425\"><strong>T\u00e9mavezet\u0151 neve<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\" width=\"888\">Az onkol\u00f3giai betegek ultrafeldolgozott \u00e9lelmiszerfogyaszt\u00e1si szok\u00e1sai<\/td>\n<td style=\"width: 49.9636%\" width=\"257\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m, Dr. P\u00e1lfi Erzs\u00e9bet<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Off-label drug use in oncology\u00a0<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Real world data of tucatinib<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Immun checkpoint inhibitors &#8211; Real world data of pembrolizumab<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Immun checkpoint inhibitors &#8211; Real world data of nivolumab<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Antibody-Drug Conjugates (ADCs) &#8211; Real world data of sacituzumab-govitecan<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Antibody-Drug Conjugates (ADCs) &#8211; Real world data of trastuzumab-deruxtecan<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern oncotherapies &#8211; Antibody-Drug Conjugates (ADCs) &#8211; Real world data of trastuzumab-emtansine<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern onkoter\u00e1pi\u00e1k &#8211; Antitest-Gy\u00f3gyszer Konjug\u00e1tumok &#8211; Val\u00f3s k\u00f6rnyezetben keletkezett adatok sacituzumab-govetecan-nal<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern onkoter\u00e1pi\u00e1k &#8211; Antitest-Gy\u00f3gyszer Konjug\u00e1tumok &#8211; Val\u00f3s k\u00f6rnyezetben keletkezett adatok trastuzumab-emtansine-nal<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Modern onkoter\u00e1pi\u00e1k &#8211; Antitest-Gy\u00f3gyszer Konjug\u00e1tumok &#8211; Val\u00f3s k\u00f6rnyezetben keletkezett adatok trastuzumab-deruxtecan-nal<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Premedication in oncology practice &#8211; Prevention of side effects<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Quality controll and quality assurance of oncotherapy\u00a0<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Endocrinological side effects of HER-2 targeted therapies\u00a0<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Safety and tolerability of established chemotherapeutic agents &#8211; Analysis of real world data<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Val\u00f3s k\u00f6rnyezetben keletkezett adatok elemz\u00e9se az onkol\u00f3gi\u00e1ban &#8211; Gy\u00f3gyszerbiztons\u00e1gi adatok monitoroz\u00e1sa az eg\u00e9szs\u00e9g\u00fcgyi tudom\u00e1nyos szakirodalomban<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Analysis of real world data &#8211; Drug safety surveillance in scientific medical literature<\/td>\n<td style=\"width: 49.9636%\">Dr. Bal\u00e1zs M\u00e1t\u00e9 \u00c1d\u00e1m<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.9636%\">Hazai, feln\u0151tt kor\u00fa Williams-Beuren szindr\u00f3m\u00e1s betegek sz\u00e9nhidr\u00e1t-anyagcsere zavarainak vizsg\u00e1lata<\/td>\n<td style=\"width: 49.9636%\">Dr. Balogh D\u00f3ra Marietta, Dr. Reismann P\u00e9ter<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2025\/2026-os tan\u00e9v Antihypertenz\u00edv ter\u00e1pia k\u00fcl\u00f6nb\u00f6z\u0151 k\u00f3rk\u00e9pekben Dr. Barna Istv\u00e1n (PhD) Obezit\u00e1s diagnosztik\u00e1ja Dr. Barna Istv\u00e1n Obezit\u00e1s kezel\u00e9se Dr. Barna Istv\u00e1n Ter\u00e1pia-rezisztens hypertonia\u00a0 \u00a0\u00a0 Dr. Tisl\u00e9r Andr\u00e1s (PhD) \u00a0ENDOKRINOL\u00d3IA-DIABETOL\u00d3GIA-ANYAGCSERE \u00c9letmin\u0151s\u00e9get befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k vizsg\u00e1lata kezelt primer hyperthyreosisban Dr. Bakos Bence (PhD) A metformin diabetesen t\u00fali ter\u00e1pi\u00e1s hat\u00e1sai Dr. Ger\u0151 L\u00e1szl\u00f3 (MTA doktora) V\u00e9rcukor-adatb\u00e1zisok elemz\u00e9se Dr. Kempler P\u00e9ter &hellip;<\/p>\n","protected":false},"author":102365,"featured_media":0,"parent":9092,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[99],"class_list":["post-10472","page","type-page","status-publish","hentry","tag-aok-rektori-palyazat"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"1970-01-01 01:00:00","action":"","terms":[],"taxonomy":"","browser_timezone_offset":0},"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/pages\/10472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/users\/102365"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/comments?post=10472"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/pages\/10472\/revisions"}],"predecessor-version":[{"id":11483,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/pages\/10472\/revisions\/11483"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/pages\/9092"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/media?parent=10472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/categories?post=10472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/tdk\/wp-json\/wp\/v2\/tags?post=10472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}